Dose-confirmatory Bridging Study in Total Hip Replacement

Clinical trial NCT01205932 · COMPLETED

Trial details

NCT number: NCT01205932
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2010-09-01
Primary completion: 2011-06-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.